U.S. flag

An official website of the United States government

NM_000506.3(F2):c.1139T>C (p.Met380Thr) AND Congenital prothrombin deficiency

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 1, 1992
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002468928.8

Allele description [Variation Report for NM_000506.3(F2):c.1139T>C (p.Met380Thr)]

NM_000506.3(F2):c.1139T>C (p.Met380Thr)

Gene:
F2:coagulation factor II, thrombin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000506.3(F2):c.1139T>C (p.Met380Thr)
Other names:
F2, MET337THR; M337T
HGVS:
  • NC_000011.10:g.46728004T>C
  • NG_008953.1:g.13812T>C
  • NM_000506.5:c.1139T>CMANE SELECT
  • NP_000497.1:p.Met380Thr
  • LRG_551:g.13812T>C
  • NC_000011.9:g.46749554T>C
  • P00734:p.Met380Thr
Protein change:
M380T; MET337THR
Links:
UniProtKB: P00734#VAR_006714; OMIM: 176930.0006; dbSNP: rs121918481
NCBI 1000 Genomes Browser:
rs121918481
Molecular consequence:
  • NM_000506.5:c.1139T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Congenital prothrombin deficiency
Synonyms:
HYPOPROTHROMBINEMIA; Factor II deficiency; Hereditary factor II deficiency disease; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013361; MedGen: C0272317; Orphanet: 325; OMIM: 613679

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034482OMIM
no assertion criteria provided
Pathogenic
(Nov 1, 1992)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Prothrombin Himi: a compound heterozygote for two dysfunctional prothrombin molecules (Met-337-->Thr and Arg-388-->His).

Morishita E, Saito M, Kumabashiri I, Asakura H, Matsuda T, Yamaguchi K.

Blood. 1992 Nov 1;80(9):2275-80.

PubMed [citation]
PMID:
1421398

Details of each submission

From OMIM, SCV000034482.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

This F2 variant is referred to as prothrombin Himi I.

In a girl with dysprothrombinemia (see 613679), Morishita et al. (1992) found a congenitally dysfunctional form of prothrombin, called prothrombin Himi, which was associated with reduced fibrinogen clotting activity, although it retained full hydrolytic activity toward synthetic substrates. Because previous findings suggested that the functional defect of prothrombin Himi was caused by an abnormality in the thrombin portion of the protein, Morishita et al. (1992) amplified the genomic DNA regions corresponding to exons 8 through 14 and applied single-strand conformation polymorphism analysis. Two variant conformers in exon 10 were identified in the proband with this variant: an 8751T-C transition resulting in a met337-to-thr (M337T) substitution inherited from the father, and an 8904G-A transition resulting in an arg388-to-his (R388H; 176930.0007) substitution inherited from the mother.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 3, 2024